Slide 1: First Quarter Earnings April 23, 2014
First Quarter Earnings APRIL 23, 2014
Slide 2: Agenda
AGENDA IDEX Outlook Q1 2014 Financial Performance Q1 2014 Segment Performance • Fluid & Metering • Health & Science • Fire & Safety / Diversified Guidance Update Q&A 1
Slide 3: Replay Information
REPLAY INFORMATION Dial toll–free: 855.859.2056 International: 404.537.3406 Conference ID: #30411379 Log on to: www.idexcorp.com 2
Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act
Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those
Slide 5: IDEX Q1 Financial Performance
$0 $20 $40 $60 $80 Q1 $67 $66 2013 2014 15% 20% 25% Q1 19.2% 20.9% 2013 2014 $ .00 $ .50 $1.00 Q1 $0.74 $0.91 2013 2014 $0 $200 $400 $600 Q1 $494 $544 2013 2014 Revenue Organic: 8% growth 170 bps expansion EPS Operating Margin Free Cash Flow Organic growth and margin expansion deliver an outstanding
Slide 6: Fluid & Metering
$0 $50 $100 $150 $200 $250 Q1 $221 $225 2013 2014 $0 $50 $100 $150 $200 $250 Q1 $212 $223 2013 2014 10% 15% 20% 25% 30% Q1 22.7% 25.3% 2013 2014 Orders Revenue Q1 Revenue Mix: Organic 5% Acquisition 0% Fx 1% Total 6% Q1 Summary: Consistent organic order growth has driven strong results, and positi
Slide 7: Health & Science
$0 $50 $100 $150 $200 Q1 $179 $195 2013 2014 $0 $50 $100 $150 $200 Q1 $173 $186 2013 2014 10% 13% 15% 18% 20% Q1 18.7% 19.4% 2013 2014 Health & Science Orders Revenue Operating Margin Q1 Revenue Mix: Organic 5% Acquisition 3% Fx 0% Total 8% Q1 Summary: Teams delivered on momentum from the fourth q
Slide 8: Fire & Safety / Diversified
$0 $50 $100 $150 Q1 $117 $116 2013 2014 $0 $50 $100 $150 Q1 $112 $137 2013 2014 10% 15% 20% 25% 30% Q1 25.3% 28.9% 2013 2014 Orders Revenue 360 bps expansion Organic: 2% decline Operating Margin Q1 Revenue Mix: Organic 22% Acquisition 0% Fx 1% Total 23% Q1 Summary: Large Dispensing order, received
Slide 9: Outlook: 2014 Guidance Summary
Q2 2014 EPS estimate range: $0.85 – $0.87 Organic revenue growth: ~ 4% Operating margin: ~ 20% Tax rate: ~ 30.0% FY 2014 EPS estimate range: $3.38 – $3.45 Organic revenue growth: ~ 4% – 5% Operating margin: > 20% Minimal FX impact Other modeling items • Tax rate: ~ 29.0% – 29.5% • Cap Ex: ~ $40M - $
Slide 10: Q&A
Q&A 9